Healthcare • Biotechnology
EODHD (TTM) · as of Oct 13, 2026
End-of-day close from stored market data, not a live quote.
Sign in to see your position size
We’ll show you if AUPH is in your portfolio and how much it contributes.
Sign inLoading market dates
No upcoming ex-dividend date announced
No 8-K filings in the last 30 days.
41 top institutions tracked
Last 13F trend: accumulating (light)
Unlock crowding heatmapUnlock filer discoverySentiment: neutral
Last trade: sell 33 days ago
Red flags: 0
283 filers reported a long position in AUPH for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
| Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | $221.4M | 13M | +6.7% |
| BlackRock, Inc. | $139M | 8.2M | +4.4% |
| GOLDMAN SACHS GROUP INC | $95.4M | 5.6M | +292% |
| NEA Management Company, LLC | $67.4M | 4M | Unchanged |
| TWO SIGMA INVESTMENTS, LP | $58.8M | 3.5M | +1.1% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $55.4M | 3.3M | -0.6% |
| STATE STREET CORP | $43.9M | 2.6M | +2.5% |
| MORGAN STANLEY | $39.2M | 2.3M | +3.4% |
| MARSHALL WACE, LLP | $34.7M | 2M | +9% |
| GEODE CAPITAL MANAGEMENT, LLC | $28.9M | 1.7M | +10.8% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.